Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

Background: We present the case of a 50-year-old female whose metastatic pancreatic neuroendocrine tumor (pNET) diagnosis was delayed by the COVID-19 pandemic. The patient was in critical condition at the time of diagnosis due to the extensive tumor burden and failing liver functions. The clinical d...

Full description

Bibliographic Details
Main Authors: Judita Szkukalek, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga, Júlia Déri, Dóra Lakatos, Dóra Tihanyi, Barbara Vodicska, Richárd Schwáb, Gábor Pajkos, Edit Várkondi, István Vályi-Nagy, Dorottya Valtinyi, Zsuzsanna Nagy, István Peták
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Diagnostics
Subjects:
pancreatic neuroendocrine tumor
molecular diagnostics
liquid biopsy
cfDNA
large panel sequencing
clinical decision support system
Online Access:https://www.mdpi.com/2075-4418/11/10/1850

Internet

https://www.mdpi.com/2075-4418/11/10/1850

Similar Items